[1. Karim SM, Zekri J. Chemotherapy for small cell lung cancer: a comprehensive review. Oncol Rev 2012;6:16-36.10.4081/oncol.2012.e4]Search in Google Scholar
[2. Yeasmin S, Nakayama K, Ishibashi M, Oride A, Katagiri A, Purwana IN, Iida K, Nakayama N, Ishikura H, Miyazaki K. Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel- and carboplatin-based chemotherapy in an ovarian cancer patient: a case report and literature review. Int J Gynecol Cancer 2008;18(6):1371-6.10.1111/j.1525-1438.2007.01185.x18217963]Open DOISearch in Google Scholar
[3. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies. Eur J Cancer 2008;44:1507-15.10.1016/j.ejca.2008.04.01818571399]Search in Google Scholar
[4. Koklu H, Tufan A, Erkul Y, Akyurek N, Civelek R. Secondary acute myeloid leukemia arising early after cyclophosphamide treatment. Int J Clin Pharm 2015;37(2):289-91.10.1007/s11096-015-0069-425612567]Search in Google Scholar
[5. See HT, Thomas DA, Bueso-Ramos C, Kavanagh J. Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer. Int J Gynecol Cancer 2006;16:236-40.10.1111/j.1525-1438.2006.00491.x16515597]Open DOISearch in Google Scholar
[6. Bhatia S. Therapy-related myelodysplasia and acute myeloid leukemia. Semin Oncol. 2013; 40(6):10-2410.1053/j.seminoncol.2013.09.013386774324331189]Open DOISearch in Google Scholar
[7. Gajendra A, Sharma A, Sharma R, Gupta SK, Sood N, Sachdev R. Hodkin Lymphoma in a case of chronic myeloid leukemia treated with tyrosine kinase inhibitors. Turk Patoloji Derg 2017; (ahead of print).10.5146/tjpath.2016.0136828272671]Search in Google Scholar
[8. Lucy A. Godley, Richard A. Larson. Therapy-related Myeloid Leukemia. Semin Oncol 2008;35(4):418–29.10.1053/j.seminoncol.2008.04.012260044518692692]Search in Google Scholar
[9. Armitage JO, Carbone PP, Connors JM, Levine A, Bennett JM, Kroll S. Treatment-related myelodysplasia and acute leukemia in non-Hodgkin’s lymphoma patients. J Clin Oncol 2003;21(5):897-906.10.1200/JCO.2003.07.11312610191]Open DOISearch in Google Scholar
[10. Pinheiro RF, Chauffaille ML. Myelodysplastic syndrome secondary to chemotherapy or radiotherapy - treatment-related MDS. Rev Bras Hematol Hemoter 2006;28(3):201-3.10.1590/S1516-84842006000300010]Search in Google Scholar
[11. Pedersen-Bjergaard J, Andersen MK, Andersen MT, Christiansen DH. Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 2008;22: 240–810.1038/sj.leu.240507818200041]Search in Google Scholar
[12. Seymour JF, Juneja SK, Campbell LJ, Ellims PH, Estey EH, Prince HM. Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy. Leukemia 1999;13(11):1735-40.10.1038/sj.leu.240155210557046]Search in Google Scholar
[13. Tasaka T, Matsuhashi Y, Uehara E, Tamura T, Kakazu N, Abe T, Nagai M. Secondary acute monocytic leukemia with a translocation t(8;16) (p11;p13): case report and review of the literature. Leuk Lymphoma 2004;45(3):621-5.10.1080/1042819031000159305815160929]Search in Google Scholar
[14. Ishikawa M, Nakayama K, Rahman MT, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Iida K, Nakayama N, Miyazaki K. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report. Eur J Gynaec Oncol 2014;35(4):443-8.]Search in Google Scholar
[15. Takagi H, Ichigo S, Matsunami K, Takagi H, Ikeda T, Murase T, Imai A. Occurrence of myelodysplastic syndrome during paclitaxel and carboplatin-based chemotherapy for recurrent ovarian cancer: Case report. Open J Obst Gynec 3:232-4.10.4236/ojog.2013.32043]Search in Google Scholar
[16. Noronha V, Berliner N, Ballen KK, Lacy J, Kracher J, Baehring J, Henson JW. Treatment-related my elodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: Case study and review of the literature. Neuro-oncol 2006;8(3):280–3.10.1215/15228517-2006-003187195016728498]Search in Google Scholar
[17. Kumar CC. Genetic Abnormalities and Challenges in the Treatment of Acute Myeloid Leukemia. Genes Cancer 2011;2(2):95–107.10.1177/1947601911408076311124521779483]Search in Google Scholar
[18. Josting A, Wiedenmann S, Franklin J, May M, Sieber M, Wolf J, Engert A, Diehl V. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin’s disease: a report from the German Hodgkin’s lymphoma study group. J Clin Oncol 2003;21(18):3440-6.10.1200/JCO.2003.07.16012668650]Search in Google Scholar
[19. Ng AK, Patricia Bernardo MV, Weller E, Backstrand K, Silver B, Marcus KC, Tarbell NJ, Stevenson MA, Friedberg JW, Mauch PM. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002;100:1989-96.10.1182/blood-2002-02-063412200357]Search in Google Scholar
[20. Groen HJ, Fokkema E, Biesma B, Kwa B, van Putten JW, Postmus PE, Smit EF. Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant schedule. J Clin Oncol 1999;17(3):927-32.10.1200/JCO.1999.17.3.92710071286]Open DOISearch in Google Scholar